Proton pump inhibitors and osteoporosis risk: exploring the role of TRPM7 channel
Author:
Funder
Uka Tarsadia University Research Promotion Scheme
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00228-021-03237-3.pdf
Reference31 articles.
1. Liao S, Gan L, Mei Z (2019) Does the use of proton pump inhibitors increase the risk of hypomagnesemia: an updated systematic review and meta-analysis. Medicine 98(13)
2. Thong BKS, Ima-Nirwana S, Chin KY (2019) Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved. Int J Environ Res Public Health 16(9):1571. https://doi.org/10.3390/ijerph16091571
3. Bahtiri E, Islami H, Hoxha R, Gashi A, Thaçi K, Karakulak Ç, Qorraj-Bytyqi H (2017) Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study. Turk J Gastroenterol 28(2):104-109. https://doi.org/10.5152/tjg.2016.0284
4. Makunts T, Cohen IV, Awdishu L, Abagyan R (2019) Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis. Sci Rep 9(1):1–10. https://doi.org/10.1038/s41598-019-39335-7
5. Zou ZG, Rios FJ, Montezano AC, Touyz, RM (2019) TRPM7, magnesium, and signaling. Int J Mol Sci 20(8):1877. https://doi.org/10.3390/ijms20081877
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Proton pump inhibitors, bone and phosphocalcic metabolism;Joint Bone Spine;2024-09
2. THE FOCUS ON INCREASED RISK OF FRACTURES IN THEIR PROLONGED USE;Acta medica Eurasica;2024-03-28
3. Roles of TRPM7 in ovarian cancer;Biochemical Pharmacology;2023-11
4. Advances in the interaction between endoplasmic reticulum stress and osteoporosis;Biomedicine & Pharmacotherapy;2023-09
5. The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study;Journal of Cancer Research and Clinical Oncology;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3